• Invest
    Investment Suite
    Stocks
    Mutual Funds
    Future and Options
    IPO
    Exchange Traded Funds
    Commodity
    Stockcase (Stock Baskets)
    Currency
    Non Convertible Debentures
    Sovereign Gold Bond
    Exclusive
    NRI Account
    Corporate/HUF Trading Account
    Private Client Group
    Features
    SipIt
    MTF
    Investment Suite
    Exclusive
    Features
  • Platform
    Product Suite
    Kotak Neo App & Web
    Nest Trading Terminal
    NEO Trade APIs
    Features and Tools
    MTF
    Securities Accepted as Collateral
    Margin Requirements
    Equity Screeners
    Payoff Analyzer
    Calculators
    SIP Calculator
    Lumpsum Calculator
    Brokerage Calculator
    Margin Calculator
    MTF Calculator
    SWP Calculator
    CAGR Calculator
    Simple Interest Calculator
    ELSS Calculator
    Step up SIP Calculator
    All Calculators
    Product Suite
    Features and Tools
    Calculators
  • Pricing
  • Research
    Research Calls
    Long Term calls
    Short Term calls
    Intraday calls
    Derivatives calls
    Pick of the week
    Top Monthly Picks
    Research Reports
    Fundamental Research Report
    Technical Research Report
    Derivative Research Report
    Research Calls
    Research Reports
  • Market
    Stocks
    Share Market Today
    Large Cap
    Mid Cap
    Small Cap
    Indices
    Nifty 50
    Bank Nifty
    FinNifty
    Nifty Midcap India
    VIX
    All Indian Indices
    Mutual Funds
    SBI Mutual Funds
    HDFC Mutual Funds
    Axis Mutual Funds
    ICICI Prudential Mutual Funds
    Nippon India Mutual Funds
    All AMC's
    IPO
    Upcoming IPO
    Current IPO
    Closed IPO
    Recently Listed IPO
    Stocks
    Indices
    Mutual Funds
    IPO
  • Learn
    Resource
    Market Ready
    Kotak Insights
    Infographic
    Podcast
    Webinars
    Youtube Channel
    Quarterly Results
    Investing Guide
    Demat Account
    Trading Account
    Share Market
    Intraday Trading
    IPO
    Mutual Funds
    Commodities
    Currency
    Futures & Options
    Derivatives
    Margin Trading
    Events
    Budget 2025
    Muhurat Trading
    Share Market Holiday
    Market Outlook 2025
    Resource
    Investing Guide
    Events
  • Partner
    Business Associates
    Kotak Connect Plus
    Startup connect
  • Support
    FAQs
    Circulars
    Bulletins
    Contact Us
    Forms Download
    Get your Statement
​

Dr Agarwals Health Care Ltd's Q3FY25 Quarter Results

Dr Agarwals Health Care Ltd's revenue - YoY
  • 15 Feb 2025
  • Dr Agarwals Health Care Ltd reported a - quarter-on-quarter (QoQ) - in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a - of -.
  • Its expenses for the quarter were - by - QoQ and - - YoY.
  • The net profit - - QoQ and - - YoY.
  • The earnings per share (EPS) of Dr Agarwals Health Care Ltd stood at 0.7 during Q3FY25.
(₹ crores) Q3FY25 Q2FY25 Q3FY24 QoQ (%) YoY (%)
Total Income
443.43
0.00
0.00
-
-
Total Expenses
402.44
0.00
0.00
-
-
Profit Before Tax
40.99
-
-
NaN%
NaN%
Tax
12.75
0.00
0.00
-
-
Profit After Tax
28.24
0.00
0.00
-
-
Earnings Per Share
0.70
0.00
0.00
-
-

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Dr Agarwals Health Care Ltd is a prominent player in the healthcare sector, specializing in offering a wide range of medical services. The company is known for its chain of eye hospitals, which provide comprehensive ophthalmic services including surgeries, treatments, and consultations. Dr Agarwals Health Care Ltd has established a strong presence across India and has expanded its reach internationally. Recent developments in the company include expansion of its network through new facility openings and incorporation of advanced medical technologies to enhance patient care. Specific recent developments or strategic changes for the current reporting period are not available in the provided data.

In the third quarter of the fiscal year 2025 (Q3FY25), Dr Agarwals Health Care Ltd reported a total income of ₹443.43 crores. As this is the only quarter with financial data provided, comparative analysis with the previous quarter (Q2FY25) or the same quarter of the previous year (Q3FY24) is not applicable. Therefore, no quarter-over-quarter (QoQ) or year-over-year (YoY) changes in total income can be calculated or discussed.

For Q3FY25, Dr Agarwals Health Care Ltd recorded a Profit Before Tax (PBT) of ₹40.99 crores. After accounting for taxes amounting to ₹12.75 crores, the Profit After Tax (PAT) stood at ₹28.24 crores. The Earnings Per Share (EPS) was reported as ₹0.70 for the same period. Since there is no previous data available for Q2FY25 or Q3FY24, changes in profitability metrics such as QoQ or YoY cannot be calculated. As such, trends in profitability over time cannot be assessed from the provided data.

In the third quarter of FY25, Dr Agarwals Health Care Ltd incurred total expenses of ₹402.44 crores against its total income of ₹443.43 crores. This resulted in a net operating profit margin before tax of approximately 9.24%. With the tax paid being ₹12.75 crores, the effective tax rate for the quarter can be calculated as approximately 31.10% of the Profit Before Tax. Without additional comparative data from previous quarters or years, the assessment of operational efficiency or trends in operating expenses is not feasible from the current dataset.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -

​N
​N
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]